Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
ML-SI3
Cat. No.:
OB0225LY-0265
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
ML-SI3 is a small molecule compound with potential antitumor activity that interferes with cell proliferation and survival signaling pathways.
Synonym:
891016-02-7; N-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]cyclohexyl}benzenesulfonamide; N-[2-[4-(2-Methoxyphenyl)piperazin-1-yl]cyclohexyl]benzenesulfonamide; N-(2-[4-(2-Methoxyphenyl)-1-piperazinyl]cyclohexyl)benzenesulfonamide; N-{2-[4-(2-Methoxyphenyl)-1-piperazinyl]cyclohexyl}benzenesulfonamide
CAS No.:
891016-02-7
Compound CID:
23604942
Formula:
C23H31N3O3S
Formula Weight:
429.58
Specification
Relative Density:
1.26 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
ML-SI3 can be used to study the proliferation mechanism of tumor cells or play an important role in drug screening for different cancer types.
Library Information
Targets:
Glucagon receptor; TRP/TRPV channel
Receptors:
TRP channel; GLP-1
Pathways:
GPCR/G protein; Membrane transporter/Ion channel
Plate Number:
AOCL-4
Plate Location:
d3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
8.13 mg/ml; 18.91 mM
